This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Lung Cancer
and you are
over 18
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood in the laboratory from patients receiving pemetrexed disodium may help doctors learn more about the effects of pemetrexed disodium on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This laboratory study is looking at blood samples from patients with stage III or stage IV non-small cell lung cancer enrolled in clinical trial MCCRC-RC0524 to determine the effect of pemetrexed disodium on cells.

Provided treatments

  • Genetic: gene expression analysis
  • Genetic: polymorphism analysis
  • Genetic: protein expression analysis
Tris trial is registered with FDA with number: NCT00898820. The sponsor of the trial is Mayo Clinic and it is looking for 80 volunteers for the current phase.
Official trial title:
Predictive Markers of Response to Pemetrexed (Companion Study to RC0524)